Finance News – Gilead
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Investors
Stock
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Bse
Etf
Earnings
Stablecoin
Ipo
Investment
Blockchain
Revenue
Index
Solana
Trade
Sec
Interest Rates
Inflation
Token
Wall Street
Sensex
Coinbase
Treasury
Federal Reserve
Nasdaq
Traders
Nse
Profit
Bse Sensex
China
Nifty
Sp 500
Gold
Investor
Tesla
Company
Defi
Trendline
Swap Rates
Legislative Proposal
Auto Market
Class A Shares
Monetary Sovereignty
Economic Safeguards
Neptune Petrochemicals
Decathlon
Trade Alliance
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jul 17, 2025
GSKâs Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associate...
The introduction of GSK’s new therapy for itching related to primary biliary cholangitis could potentially generate significant revenue by meeting patient needs not fully addressed...
Read Full Article →
CNBC Business • Jun 18, 2025
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new...
The approval of Gilead’s biannual HIV prevention injection presents a significant development in treatment options, though its impact may be influenced by possible reductions in go...
Read Full Article →